Your browser doesn't support javascript.
Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.
Wang, Zhenling; Pan, Hailong; Jiang, Boguang.
  • Wang Z; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China. wangzhenling@scu.edu.cn.
  • Pan H; Department of Quality Management, China National Biotec Group Company Limited, 100020, Beijing, China.
  • Jiang B; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China.
Signal Transduct Target Ther ; 5(1): 198, 2020 09 14.
Article in English | MEDLINE | ID: covidwho-766064
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Interferon Type I / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2020 Document Type: Article Affiliation country: S41392-020-00306-4

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Interferon Type I / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2020 Document Type: Article Affiliation country: S41392-020-00306-4